TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biovica International AB
Closing information (x1000 NOK)
Closing information | 2024/04 (consolidated) | 2023/04 (consolidated) | 2022/04 (consolidated) |
Turnover |
7,328
|
3,507
|
1,950 |
Financial expenses |
291
|
511
|
75 |
Earnings before taxes |
-124,791
|
-114,740
|
-57,203 |
EBITDA |
-118,035
|
-105,993
|
-51,169 |
Total assets |
132,101
|
178,607
|
144,585 |
Current assets |
88,580
|
124,391
|
90,504 |
Current liabilities |
28,440
|
24,505
|
15,346 |
Equity capital |
97,151
|
143,721
|
118,322 |
- share capital |
5,634
|
3,161
|
1,811 |
Employees (average) |
37
|
31
|
25 |
Financial ratios
Fiscal year | 2024/04 (consolidated) | 2023/04 (consolidated) | 2022/04 (consolidated) |
Solvency |
73.5%
|
80.5%
|
81.8% |
Turnover per employee |
198
|
113
|
78 |
Profit as a percentage of turnover |
-1702.9%
|
-3271.7%
|
-2933.5% |
Return on assets (ROA) |
-94.2%
|
-64.0%
|
-39.5% |
Current ratio |
311.5%
|
507.6%
|
589.8% |
Return on equity (ROE) |
-128.5%
|
-79.8%
|
-48.3% |
Change turnover |
3,928
|
1,387
|
-31 |
Change turnover % |
115%
|
65%
|
-2% |
Chg. No. of employees |
6
![]() |
6
|
5 |
Chg. No. of employees % |
19%
|
24%
|
25% |
Total value of public sale
Fiscal year | 2024/04 (consolidated) | 2023/04 (consolidated) | 2022/04 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.